News Center

Actual patient. Results may vary. Actual patient. Results may vary.
Follow Us @AllerganAesthetics

Allergan Aesthetics publishes 'The Future of Aesthetics' global trends report providing unrivalled insight into future of industry

<p>-- Report is aimed at helping practitioners and the industry understand and prepare for the future by supporting the evolving needs of patients -- -- Built on robust market research and analysis...</p> …

BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval

<p>Iconic Brand Was The First Product Of Its Kind To Receive U.S. Food And Drug Administration Approval In 2002 For Aesthetic Use And Is Honoring This Milestone By Celebrating Its Loyal Patients And...</p> …

ALLERGAN AESTHETICS BRINGS DATA, INNOVATION & INDUSTRY EXPERTISE TO THE 2022 AESTHETIC AND ANTI-AGING MEDICINE WORLD CONGRESS (AMWC)

<p>-Industry leader demonstrates commitment to the future of aesthetics with forward-facing, trends report- -Meeting will signify the launch of HArmonyCa™, hybrid injectable across Europe and in...</p> …

AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting

<p>Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic...</p> …

FDA Approves JUVÉDERM® VOLBELLA® XC For Undereye Hollows

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the FDA approval of JUVÉDERM® VOLBELLA® XC for improvement of infraorbital hollows in adults over the age of 21.2 According to...</p> …

Allergan Aesthetics Announces Open Casting Call for BOTOX® Cosmetic (onabotulinumtoxinA)

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV) announced today it will be hosting an open casting call seeking people who would like to share their BOTOX® Cosmetic Story. The company...</p> …

Allergan Aesthetics Completes Acquisition of Soliton

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ: SOLY). The addition of Soliton and its technology...</p> …

Allergan Aesthetics To Present Data From Its Leading Aesthetic Portfolio At The 2021 American Society For Dermatologic Surgery Virtual Meeting

<p>Allergan Aesthetics, an AbbVie company, (NYSE: ABBV) today announced that it will present six abstracts from its leading portfolio of aesthetic treatments and products at the American Society for...</p> …

Allergan Aesthetics Celebrates Third Annual BOTOX® Cosmetic (onabotulinumtoxina) Day

<p>Let the countdown begin. Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8966951-allergan-aesthetics-alle-botox-cosmetic-day/ Allergan...</p> …

Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is continuing its commitment to breast health, awareness, restoration, and research in support of breast cancer awareness month. For the month...</p> …

DREAM™ Initiative Releases, The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas

Allergan Aesthetics, an AbbVie company, and SkinBetter Science through their DREAMTM (Driving Racial Equity in Aesthetic Medicine) initiative are supporting the development and distribution of The …

Allergan Aesthetics Continues Partnership with Girls Inc. to Empower Confidence in High School-Aged Girls Interested in STEM

Today Allergan Aesthetics, now an AbbVie company, announces its third consecutive year of partnership with Girls Inc. and debut of its Empowering Confidence Workshops, a nationwide mentoring …

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is changing the way BOTOX® Cosmetic, the #1 selling neurotoxin treatment1, is connecting with consumers. Today, the brand is launching 'See …

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio

Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and Soliton (NASDAQ: SOLY) today announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid …

SkinMedica® Launches Neck Correct Cream for Neck and Décolleté

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the launch of SkinMedica® Neck Correct Cream, the first product from the professional-grade skincare line formulated to …

CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of CoolSculpting® Elite, its next generation fat reduction system with applicators designed to complement the …

Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference

Allergan Aesthetics and Allergan, an AbbVie company (NYSE: ABBV), announced today that scientific and clinical experts in the field of neurotoxins will present results from 16 abstracts spanning …

Allergan Aesthetics Enters Into Option to Acquire Cypris Medical

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that it has entered into a warrant agreement with Cypris Medical, a privately held, medical device company based in Chicago …